Treatment with sST2 in the cisplatin-induced AKI model exhibited fewer CD4-infiltrating T cells, lower serum creatinine, and decreased acute tubular necrosis (ATN) and apoptosis as compared to the untreated controls (17). This evidence concerns the gene CD4 and acute kidney injury.